An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates

Abstract : There are currently two main techniques allowing the analytical characterization of interchain cysteine-linked antibody drug conjugates (ADCs) under native conditions, namely, hydrophobic interaction chromatography (HIC) and native mass spectrometry (MS). HIC is a chromatographic technique allowing the evaluation of drug load profile and calculation of average drug-to-antibody ratio (DAR) in quality control laboratories. Native MS offers structural insights into multiple ADC critical quality attributes, thanks to accurate mass measurement. However, both techniques can lead to misinterpretations or incomplete characterization when used as standalone methods. Online coupling of both techniques can thus potentially be of great interest, but the presence of large amounts of nonvolatile salts in HIC mobile phases makes it not easily directly compatible with native MS. Here, we present an innovative multidimensional analytical approach combining comprehensive online two-dimensional (2D)-chromatography that consists of HIC and size-exclusion chromatography (SEC), to ion mobility and mass spectrometry (IM-MS) for performing analytical characterization of ADCs under nondenaturing conditions. This setup enabled comprehensive and streamlined characterization of both native and forced degraded ADC samples. The proposed 4D methodology might be more generally adapted for online all-in-one HIC×SEC-IM×MS analysis of single proteins or analysis of protein complexes in nondenaturing conditions.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01767719
Contributor : Agnès Bussy <>
Submitted on : Monday, April 16, 2018 - 2:44:56 PM
Last modification on : Friday, November 30, 2018 - 2:18:33 PM

Identifiers

Citation

Anthony Ehkirch, Valentina d'Atri, Florent Rouvière, Oscar Hernandez-Alba, Alexandre Goyon, et al.. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates. Analytical Chemistry, American Chemical Society, 2018, 90 (3), pp.1578 - 1586. ⟨10.1021/acs.analchem.7b02110⟩. ⟨hal-01767719⟩

Share

Metrics

Record views

78